Clinical Trials
7
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)β’ Click on a phase to view related trials
Hernia Reduction Prior to Scheduled TIF Completion
- Conditions
- Fundoplication
- First Posted Date
- 2017-09-12
- Last Posted Date
- 2021-02-10
- Lead Sponsor
- EndoGastric Solutions
- Target Recruit Count
- 14
- Registration Number
- NCT03280121
- Locations
- πΊπΈ
Elkhart General Hospital, Elkhart, Indiana, United States
πΊπΈAspirus Iron River Hospital, Iron River, Michigan, United States
πΊπΈNorthern Nevada Medical Center, Sparks, Nevada, United States
The EndoGastric Solutions TEMPO Trial
- Conditions
- Gastroesophageal Reflux Disease (GERD)
- Interventions
- Drug: PPIDevice: EsophyX System with SerosaFuse fasteners
- First Posted Date
- 2012-07-24
- Last Posted Date
- 2020-11-23
- Lead Sponsor
- EndoGastric Solutions
- Target Recruit Count
- 65
- Registration Number
- NCT01647958
- Locations
- πΊπΈ
EndoGastric Solutions, Redmond, Washington, United States
Retrospective TIF Study for Treatment of Gastroesophageal Reflux Disease (GERD). The RetroTIF Study
- Conditions
- Gastroesophageal Reflux Disease (GERD)
- First Posted Date
- 2011-04-04
- Last Posted Date
- 2020-12-03
- Lead Sponsor
- EndoGastric Solutions
- Target Recruit Count
- 110
- Registration Number
- NCT01327963
- Locations
- πΊπΈ
Munroe Regional Medical Center, Ocala, Florida, United States
πΊπΈLivingston Hospital and Healthcare Services, Inc. CAH, Salem, Kentucky, United States
Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study
- Conditions
- Hiatal HerniaGastroesophageal Reflux Disease
- First Posted Date
- 2010-06-04
- Last Posted Date
- 2021-12-03
- Lead Sponsor
- EndoGastric Solutions
- Target Recruit Count
- 129
- Registration Number
- NCT01136980
- Locations
- πΊπΈ
Cedars Sinai Medical Center, Los Angeles, California, United States
πΊπΈSurgOne PC, Englewood, Colorado, United States
πΊπΈNorthwestern University, Chicago, Illinois, United States
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)
- Conditions
- Hiatal HerniaGastroesophageal Reflux Disease
- First Posted Date
- 2010-05-06
- Last Posted Date
- 2019-03-06
- Lead Sponsor
- EndoGastric Solutions
- Target Recruit Count
- 278
- Registration Number
- NCT01118585
- Locations
- πΊπΈ
Mt. Graham Regional Medical Center, Safford, Arizona, United States
πΊπΈTempe St. Luke's Hospital, Tempe, Arizona, United States
πΊπΈSwedish Medical Center and SurgOne P.C., Englewood, Colorado, United States
- Prev
- 1
- 2
- Next